TTD | Drug: D02XYA

Drug General Information
Drug ID	D02XYA
Former ID	DNCL002769
Drug Name	Astuprotimut-R
Indication	Adjuvant non-small-cell lung carcinoma; Melanoma [ICD9: 162, 172; ICD10:C33, C34, C43]		Phase 3	[522494]
Company	GlaxoSmithKline
Target and Pathway
Target(s)	Melanoma-associated antigen 3	Target Info	Modulator	[550432]
References
Ref 522494	ClinicalTrials.gov (NCT00796445) A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor. U.S. National Institutes of Health.
Ref 550432	National Cancer Institute Drug Dictionary (drug id 600553).

Drug Information